ALONGI, Pierpaolo
 Distribuzione geografica
Continente #
NA - Nord America 4.037
EU - Europa 3.068
AS - Asia 2.612
Continente sconosciuto - Info sul continente non disponibili 561
SA - Sud America 537
AF - Africa 90
OC - Oceania 4
Totale 10.909
Nazione #
US - Stati Uniti d'America 3.847
RU - Federazione Russa 932
DE - Germania 767
CN - Cina 636
IT - Italia 631
SG - Singapore 601
BR - Brasile 413
VN - Vietnam 350
HK - Hong Kong 326
BD - Bangladesh 266
PL - Polonia 231
FR - Francia 149
JP - Giappone 120
CA - Canada 88
GB - Regno Unito 76
NL - Olanda 60
IN - India 56
AR - Argentina 50
FI - Finlandia 49
KR - Corea 35
MX - Messico 31
ID - Indonesia 28
UA - Ucraina 28
IR - Iran 27
EC - Ecuador 24
SE - Svezia 24
IQ - Iraq 22
TR - Turchia 21
AT - Austria 20
JM - Giamaica 20
ZA - Sudafrica 19
ES - Italia 18
CO - Colombia 15
IE - Irlanda 15
UZ - Uzbekistan 13
LB - Libano 11
PY - Paraguay 11
TW - Taiwan 11
EG - Egitto 10
PK - Pakistan 10
AM - Armenia 9
CI - Costa d'Avorio 9
MA - Marocco 9
SA - Arabia Saudita 9
AE - Emirati Arabi Uniti 8
DZ - Algeria 8
HN - Honduras 8
NI - Nicaragua 8
PE - Perù 8
PH - Filippine 8
CR - Costa Rica 7
MY - Malesia 7
VE - Venezuela 7
CL - Cile 6
GR - Grecia 6
LT - Lituania 6
PA - Panama 6
AZ - Azerbaigian 5
CZ - Repubblica Ceca 5
GT - Guatemala 5
KE - Kenya 5
LU - Lussemburgo 5
NP - Nepal 5
PS - Palestinian Territory 5
RO - Romania 5
TN - Tunisia 5
AL - Albania 4
AU - Australia 4
BY - Bielorussia 4
NO - Norvegia 4
SC - Seychelles 4
TT - Trinidad e Tobago 4
BE - Belgio 3
BG - Bulgaria 3
CY - Cipro 3
EE - Estonia 3
ET - Etiopia 3
IL - Israele 3
JO - Giordania 3
KZ - Kazakistan 3
PT - Portogallo 3
QA - Qatar 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
BA - Bosnia-Erzegovina 2
BS - Bahamas 2
BW - Botswana 2
CH - Svizzera 2
DO - Repubblica Dominicana 2
LV - Lettonia 2
LY - Libia 2
MM - Myanmar 2
MU - Mauritius 2
NG - Nigeria 2
SN - Senegal 2
SV - El Salvador 2
UY - Uruguay 2
AO - Angola 1
AW - Aruba 1
BB - Barbados 1
Totale 10.324
Città #
San Jose 699
Secaucus 674
Ashburn 424
Singapore 312
Hong Kong 301
Council Bluffs 199
Zgierz 197
Moscow 194
Hefei 192
Los Angeles 180
Beijing 128
Ho Chi Minh City 126
Tokyo 116
Lauterbourg 94
New York 85
Hanoi 83
Palermo 77
Dallas 76
Chicago 70
Milan 67
Fairfield 63
Chandler 61
Buffalo 45
Rome 45
Santa Clara 44
Redondo Beach 33
Houston 32
São Paulo 32
Orem 31
Boardman 30
Wilmington 30
Seoul 29
Frankfurt am Main 28
Toronto 27
Seattle 25
Woodbridge 25
Helsinki 23
Atlanta 21
Cambridge 21
Warsaw 20
Lappeenranta 19
Nuremberg 18
Phoenix 18
The Dalles 18
Da Nang 17
Amsterdam 16
Montreal 16
Naples 16
Dublin 15
Mumbai 15
Altamura 14
Chennai 14
Ann Arbor 13
Denver 13
Guangzhou 13
Kyiv 13
London 13
Brooklyn 12
Des Moines 12
Haiphong 12
Medford 12
Paris 12
Elk Grove Village 11
Rio de Janeiro 11
Tashkent 11
Trento 11
Kingston 10
Vimercate 10
Abidjan 9
Brasília 9
Guayaquil 9
Mexico City 9
Newark 9
Turin 9
Vienna 9
Belo Horizonte 8
Johannesburg 8
Lawrence 8
Manchester 8
Poplar 8
Princeton 8
Salt Lake City 8
San Diego 8
San Francisco 8
Stockholm 8
Boston 7
Can Tho 7
Managua 7
Philadelphia 7
Ribeirão Preto 7
Salvador 7
Schiffdorf 7
Biên Hòa 6
Bogotá 6
Cagliari 6
Catania 6
Charlotte 6
Cleveland 6
Curitiba 6
Dongguan 6
Totale 5.584
Nome #
18F-Florbetaben PET/CT to Assess Alzheimer's Disease: A new Analysis Method for Regional Amyloid Quantification 930
10-Year Clinical Experience With 18F-Choline PET/CT: An Italian Multicenter Retrospective Assessment of 3343 Patients 884
Two Phase 3 Trials of Gantenerumab in Early Alzheimer's Disease 341
Imaging features of adrenal masses 267
Diagnostic accuracy of cerebrospinal fluid biomarkers measured by chemiluminescent enzyme immunoassay for Alzheimer disease diagnosis 197
Whole body magnetic resonance in indolent lymphomas under watchful waiting: The time is now 196
Joint survey by AIMN, AIOM, AIRO, SIU, SIUrO, and Meet-URO about the use of PSMA PET imaging in prostate cancer in Italy: technical aspects and primary staging setting 192
Applications of Artificial Intelligence, Deep Learning, and Machine Learning to Support the Analysis of Microscopic Images of Cells and Tissues 176
Clinical and prognostic value of18F-FDG-PET/CT in restaging of pancreatic cancer 164
A Systematic Review Comparing Lymphoscintigraphy and Magnetic Resonance Imaging Techniques in the Assessment of Peripheral Lymphedema 155
Molecular imaging in the diagnostic process of neuroendocrine tumors: a systematic review on unknown primary origin and suspected NETs 154
The role of PET radiomic features in prostate cancer: a systematic review 145
Artificial Intelligence and Statistical Models for the Prediction of Radiotherapy Toxicity in Prostate Cancer: A Systematic Review 143
Artificial Intelligence Applications on Restaging [18F]FDG PET/CT in Metastatic Colorectal Cancer: A Preliminary Report of Morpho-Functional Radiomics Classification for Prediction of Disease Outcome 137
Explainable radiomics for prostate cancer diagnosis 136
99mTc-labeled colloid SPECT/CT versus planar lymphoscintigraphy for sentinel lymph node detection in patients with breast cancer: a meta-analysis 132
Intra-tumoral susceptibility signals in brain gliomas: where do we stand? 129
An Update on DOTA-Peptides PET Imaging and Potential Advancements of Radioligand Therapy in Intracranial Meningiomas 128
Multiparametric MRI and Radiomics in Prostate Cancer: A Review of the Current Literature 126
Focal Pancreatic Lesions: Role of Contrast-Enhanced Ultrasonography 125
Artificial Intelligence Analysis Using MRI and PET Imaging in Gliomas: A Narrative Review 123
Impact of COVID-19 Pandemic on Cardiovascular Testing in Asia: The IAEA INCAPS-COVID Study 110
Radiomics analysis of 18F-Choline PET/CT in the prediction of disease outcome in high-risk prostate cancer: an explorative study on machine learning feature classification in 94 patients 109
Sequencing Life-Prolonging Agents in Castration-Resistant Prostate Cancer Patients: Comparison of Sequences With and Without 223Ra 106
18F-FDG PET reveals unique features of large vessel inflammation in patients with Takayasu’s arteritis 105
18F-Fluorodeoxyglucose-PET/CT in locally advanced head and neck cancer can influence the stage migration and nodal radiation treatment volumes 103
Artificial Intelligence in Breast Cancer: A Systematic Review on PET Imaging Clinical Applications 102
Advances in the In Vivo Quantitative and Qualitative Imaging Characterization of Gliomas 98
18F-FMISO PET imaging: insights over MRI in patients with glioma 98
A Cross-Validation of FDG-and Amyloid-PET Biomarkers in Mild Cognitive Impairment for the Risk Prediction to Dementia due to Alzheimer's Disease in a Clinical Setting 97
Worldwide Disparities in Recovery of Cardiac Testing 1 Year Into COVID-19 97
Letter to the Editor Regarding “The Radiological Imaging Features of Easily Misdiagnosed Epithelioid Glioblastoma in Seven Patients” 97
The Added Value of [18F]Choline PET/CT in Low-Risk Prostate Cancer Staging: A Case Report 94
Amyloid PET in the diagnostic workup of neurodegenerative disease 93
Radiomics Analysis of Brain [18F]FDG PET/CT to Predict Alzheimer’s Disease in Patients with Amyloid PET Positivity: A Preliminary Report on the Application of SPM Cortical Segmentation, Pyradiomics and Machine-Learning Analysis 93
18F-FDG PET/CT for Early Postradiotherapy Assessment in Solitary Bone Plasmacytomas 93
Subcutaneous Uptake on [18F]Florbetaben {PET}/{CT}: a Case Report of Possible Amyloid-Beta Immune-Reactivity After {COVID}-19 Vaccination 92
Myeloid and Lymphoid Disorders in Geriatric Patients 92
18F-FACBC in prostate cancer: A systematic review and meta-analysis 91
Diagnostic accuracy of FDG PET/CT for clinical evaluation at the end of treatment of HL and NHL: a comparison of the Deauville Criteria (DC) and the International Harmonization Project Criteria (IHPC) 90
18F-fluoroethylcholine (18F-cho) PET/MRI functional parameters in pediatric astrocytic brain tumors 87
Prostate-Specific Membrane Antigen Positron Emission Tomography Oncological Applications beyond Prostate Cancer in Comparison to Other Radiopharmaceuticals 85
Sporadic and von Hippel–Lindau Related Hemangioblastomas of Brain and Spinal Cord: Multimodal Imaging for Intraoperative Strategy 85
The role of molecular imaging in the frame of the revised dementia with Lewy body criteria 84
Stereotactic body radiation therapy for liver oligometastases: Predictive factors of local response by 18F-FDG-PET/CT 84
Prognostic and diagnostic value of [18F]FDG-PET/CT in restaging patients with small cell lung carcinoma: An Italian multicenter study 82
Assessment of response to treatment in paediatric bone sarcomas by means of PET imaging 82
18F-FDG PET-Derived Volume-Based Parameters to Predict Disease-Free Survival in Patients with Grade III Breast Cancer of Different Molecular Subtypes Candidates to Neoadjuvant Chemotherapy 79
Sequencing radium 223 and other life-prolonging agents in castration-resistant prostate cancer patients 78
[11C]choline-PET-guided helical tomotherapy and estramustine in a patient with pelvic-recurrent prostate cancer: Local control and toxicity profile after 24 months 75
PSMA-PET: is the time to say goodbye to metabolic radiopharmaceuticals in prostate cancer? 75
Fracture risk and survival outcomes in metastatic castration-resistant prostate cancer patients sequentially treated with abiraterone acetate and RADIUM-223 75
Recurrent renal cell carcinoma: clinical and prognostic value of FDG PET/CT 74
Impact of COVID-19 on Cardiovascular Testing in the United States Versus the Rest of the World 73
Imaging biomarkers of neuroinflammations: TSPO agents 72
Brain PET/CT using prostate cancer radiopharmaceutical agents in the evaluation of gliomas 72
Head-to-Head Comparison of FDG and Radiolabeled FAPI PET: A Systematic Review of the Literature 70
Clinical impact of18f-fdg pet/ct in the diagnostic workup of pancreatic ductal adenocarcinoma: A systematic review 70
The role of pet in supratentorial and infratentorial pediatric brain tumors 69
Hypoxia pathway: 18F-FAZA 69
Impact of COVID-19 on the imaging diagnosis of cardiac disease in Europe 68
PSMA and Choline PET for the Assessment of Response to Therapy and Survival Outcomes in Prostate Cancer Patients: A Systematic Review from the Literature 68
Reply to letter of Adams and Kwee: Critical considerations on the predictive value of end-of-treatment FDG/PET in lymphoma 66
Role of molecular imaging in the management of patients affected by inflammatory bowel disease: State-of-the-art 66
Positron emission tomography with computed tomography imaging (PET/CT) for the radiotherapy planning definition of the biological target volume: PART 2 65
Predictive and prognostic value of 18F-DOPA PET/CT in patients affected by recurrent medullary carcinoma of the thyroid 65
Megavoltage CT images of helical tomotherapy unit for radiation treatment simulation: Impact on feasibility of treatment planning in a prostate cancer patient with bilateral femoral prostheses 65
Choline PET/CT and intraoperative management of primary brain tumors. New insights for contemporary neurosurgery 64
Choline-PET/CT in the differential diagnosis between cystic glioblastoma and intraparenchymal hemorrhage 64
PET Imaging in Gliomas: Clinical Principles and Synergies with MRI 64
Unconventional non-amino acidic PET radiotracers for molecular imaging in gliomas 63
Initial results of the use of a novel semiquantitative parameter in three-phase bone scan to predict 99mTc-HMPAO-labeled leukocyte scintigraphy in patients with unilateral total knee replacement 62
The role of 18F-Fluorodeoxyglucose PET/CT in restaging patients with small cell lung cancer: A systematic review 62
Diagnostic and prognostic value of 18F-FDG PET/CT in recurrent germinal tumor carcinoma 61
Predictive value of 18F-FDG PET/CT in restaging patients affected by ovarian carcinoma: a multicentre study 61
Evaluation of an optimized [18F]fluoro-deoxy-glucose positron emission tomography voxel-wise method to early support differential diagnosis in atypical Parkinsonian disorders 61
Editorial: Improving our understanding of the management and pathogenesis of rare and neglected tumors of the central and peripheral nervous system 60
PET neuroimaging: Insights on dystonia and Tourette syndrome and potential applications 60
PET/CT for the diagnostic assessment of patients with testicular cancer 60
Somatostatin Receptor PET/CT Imaging for the Detection and Staging of Pancreatic NET: A Systematic Review and Meta-Analysis 59
The Rise of Total-Body PET/CT: Advancing Molecular Imaging Toward Early Cancer Detection and Potential Future Application in Prevention Healthcare 58
FAPi-Based Agents in Thyroid Cancer: A New Step towards Diagnosis and Therapy? A Systematic Review of the Literature 57
Sentinel node identification with [99mTc]-tilmanocept SPECT/CT: a pictorial essay of clinical applications 57
Choline PET/CT features to predict survival outcome in high-risk prostate cancer restaging: a preliminary machine-learning radiomics study 56
Pet and spect imaging in the SARS-CoV-2 pandemic 55
Prevalence of interstitial pneumonia suggestive of COVID-19 at 18F-FDG PET/CT in oncological asymptomatic patients in a high prevalence country during pandemic period: a national multi-centric retrospective study 55
Neuropsychological and FDG-PET profiles in VGKC autoimmune limbic encephalitis 53
The Value of Semiquantitative Parameters Derived from 18F-FDG PET/CT for Predicting Response to Neoadjuvant Chemotherapy in a Cohort of Patients with Different Molecular Subtypes of Breast Cancer 53
Molecular Imaging of Vulnerable Plaque 53
Prostate-specific membrane antigen-PET/CT may result in stage migration in prostate cancer: Performances, quantitative analysis, and potential criticism in the clinical practice 52
Positron emission tomography with computed tomography imaging (PET/CT) for the radiotherapy planning definition of the biological target volume: PART 1 52
Prefrontal Cortical Stimulation in Tourette Disorder: Proof-of-concept Clinical and Neuroimaging Study 52
Inflammatory Bowel Diseases 52
Theragnostic use of radiolabelled dota-peptides in meningioma: From clinical demand to future applications 49
Radiation treatment of lymph node recurrence from prostate cancer: Is 11C-choline PET/CT predictive of survival outcomes? 48
Developing role of nuclear medicine in melanoma imaging in melanoma management: What's new under the sun? 48
Diagnostic and prognostic value of 18F-FDG PET/CT in comparison with morphological imaging in primary adrenal gland malignancies - A multicenter experience 47
PET/CT for the diagnostic assessment of patients with renal cancer 47
Could 68-Ga PSMA PET/CT become a new tool in the decision-making strategy of prostate cancer patients with biochemical recurrence of PSA after radical prostatectomy? A preliminary, monocentric series 46
The role of PET/CT in the evaluation of patients affected by limbic encephalitis: A systematic review of the literature 43
Totale 10.677
Categoria #
all - tutte 31.533
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.533


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202284 0 0 0 2 1 6 11 4 8 13 25 14
2022/2023218 17 35 3 23 41 34 14 10 14 5 13 9
2023/2024145 9 15 4 13 13 33 10 9 11 1 10 17
2024/20251.604 15 20 18 14 19 20 31 334 285 279 139 430
2025/20267.534 342 862 577 1.427 458 693 697 644 595 271 565 403
2026/20271.054 241 240 441 132 0 0 0 0 0 0 0 0
Totale 10.909